M.H. Li, R. Xiao, J.B. Li, Q. Zhu  Osteoarthritis and Cartilage 

Slides:



Advertisements
Similar presentations
Regenerative Options for Knee Osteoarthritis Cellular Medicine Chris Evans PhD REHABILATATION MEDICINE RESEARCH CENTER.
Advertisements

Full-thickness cartilage defects repaired by human induced pluripotent stem cells (IPSCS)-derived mesenchymal stem cells and plga scaffolds D. Shi, X.
CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
Expression pattern differences between osteoarthritic chondrocytes and mesenchymal stem cells during chondrogenic differentiation  P. Bernstein, C. Sticht,
Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review  Y. Zhu, M. Yuan, H.Y. Meng, A.Y. Wang,
The disease modifying osteoarthritis drug diacerein is able to antagonize pro inflammatory state of chondrocytes under mild mechanical stimuli  B. Steinecker-Frohnwieser,
Celecoxib exerts protective effects on extracellular matrix metabolism of mandibular condylar chondrocytes under excessive mechanical stress  S.-C. Su,
Muscle cell-derived factors inhibit inflammatory stimuli-induced damage in hMSC- derived chondrocytes  R.S. Rainbow, H. Kwon, A.T. Foote, R.C. Preda, D.L.
Pressure and inflammatory stimulation induced increase of cadherin-11 is mediated by PI3K/Akt pathway in synovial fibroblasts from temporomandibular joint 
Full-thickness cartilage defects repaired by human induced pluripotent stem cells (IPSCS)-derived mesenchymal stem cells and plga scaffolds  D. Shi, X.
Regenerative Stromal Cell Therapy in Allogeneic Hematopoietic Stem Cell Transplantation: Current Impact and Future Directions  Jeffery J. Auletta, Kenneth.
Stem cells in dentistry – Part II: Clinical applications
Regulation of mesenchymal stem cell chondrogenesis by glucose through protein kinase C/transforming growth factor signaling  T.-L. Tsai, P.A. Manner,
Mesenchymal stromal cells for cartilage repair in osteoarthritis
Peroxynitrite-modified collagen-II induces p38/ERK and NF-κB-dependent synthesis of prostaglandin E2 and nitric oxide in chondrogenically differentiated.
CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
Metabolic stress-induced joint inflammation and osteoarthritis
Stem cell therapies for liver failure and cirrhosis
Reprogramming toward Heart Regeneration: Stem Cells and Beyond
TGFβ inhibition during expansion phase increases the chondrogenic re-differentiation capacity of human articular chondrocytes  R. Narcisi, L. Signorile,
X. Zhang, I. Prasadam, W. Fang, R. Crawford, Y. Xiao 
Management of advanced renal cancer
Aaron M. Abarbanell, MD, Arthur C. Coffey, MD, John W
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Bone morphogenetic protein 2/SMAD signalling in human ligamentocytes of degenerated and aged anterior cruciate ligaments  K. Ruschke, C. Meier, M. Ullah,
Mesenchymal Cells in Colon Cancer
Anti-apoptotic effect of transforming growth factor-β1 on human articular chondrocytes: role of protein phosphatase 2A  M. Lires-Deán, B.S., B. Caramés,
Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short- term osteoarthritic synovium and cartilage explant culture  G.M. van.
An in vivo cross-linkable hyaluronan gel with inherent anti-inflammatory properties reduces OA cartilage destruction in female mice subjected to cruciate.
Transplantation of autologous endothelial progenitor cells in porous PLGA scaffolds create a microenvironment for the regeneration of hyaline cartilage.
Aging-related inflammation in osteoarthritis
MicroRNA-320 regulates matrix metalloproteinase-13 expression in chondrogenesis and interleukin-1β-induced chondrocyte responses  F. Meng, Z. Zhang, W.
M. Murata, M.D., Ph.D., K. Yudoh, M.D., Ph.D., K. Masuko, M.D., Ph.D. 
Comparative analysis with collagen type II distinguishes cartilage oligomeric matrix protein as a primary TGFβ-responsive gene  H. Li, D.R. Haudenschild,
Bone Morphogenetic Proteins and articular cartilage
Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation  A.
Krishanu Saha, Rudolf Jaenisch  Cell Stem Cell 
H.H. Lee, M.J. O'Malley, N.A. Friel, C.R. Chu 
Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation  D.C. Lacey, P.J. Simmons,
M.M.-G. Sun, F. Beier  Osteoarthritis and Cartilage 
Z. Zhang, W. Liao, Z. Zhang, X. Duan, C. Hou 
Ahmed Mohyeldin, Tomás Garzón-Muvdi, Alfredo Quiñones-Hinojosa 
Salubrinal reduces expression and activity of MMP13 in chondrocytes
Stem cell therapy for human cartilage defects: a systematic review
Modulation of inflammation by chondroitin sulfate
N.D. Miljkovic, M.D., Ph.D., G.M. Cooper, Ph.D., K.G. Marra, Ph.D. 
Anti-inflammatory activity of chondroitin sulfate
Bone–cartilage interface crosstalk in osteoarthritis: potential pathways and future therapeutic strategies  X.L. Yuan, H.Y. Meng, Y.C. Wang, J. Peng,
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Biological actions of curcumin on articular chondrocytes
Diarmaid Dominic Houlihan, Philip Noel Newsome  Gastroenterology 
Hematology Journal Club
Emerging role of endothelin receptor type B in regulating chondrogenic and hypertrophic changes of human mesenchymal stem cells  M. Au, M. Zhu, W.-J.
Bone Morphogenetic Proteins and articular cartilage
The hallmarks of osteoarthritis and the potential to develop personalised disease- modifying pharmacological therapeutics  D.P. Tonge, M.J. Pearson, S.W.
A peptide temporally enhanced chondrogenesis of mesenchymal stem cells
Celecoxib exerts protective effects on extracellular matrix metabolism of mandibular condylar chondrocytes under excessive mechanical stress  S.-C. Su,
674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.
Novel juvenile factors for cartilage regeneration
Identification of opticin, a member of the small leucine-rich repeat proteoglycan family, in human articular tissues: a novel target for MMP-13 in osteoarthritis 
Osteoarthritis year in review 2015: biology
The emerging role of endothelin-1 in the pathogenesis of subchondral bone disturbance and osteoarthritis  A. Sin, W. Tang, C.Y. Wen, S.K. Chung, K.Y.
Volume 82, Issue 7, Pages (October 2012)
Clinical Gastroenterology and Hepatology
Claudia Loebel, Jason A. Burdick  Cell Stem Cell 
Discovery of a small molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying treatment for knee osteoarthritis  J.D. Hood, V.
Volume 70, Issue 2, Pages (July 2006)
Volume 72, Issue 8, Pages (October 2007)
Structured three-dimensional co-culture of mesenchymal stem cells with chondrocytes promotes chondrogenic differentiation without hypertrophy  M.E. Cooke,
Apoptosis: Activate NF-κB or die?
Presentation transcript:

Regenerative approaches for cartilage repair in the treatment of osteoarthritis  M.H. Li, R. Xiao, J.B. Li, Q. Zhu  Osteoarthritis and Cartilage  Volume 25, Issue 10, Pages 1577-1587 (October 2017) DOI: 10.1016/j.joca.2017.07.004 Copyright © 2017 Osteoarthritis Research Society International Terms and Conditions

Fig. 1 Convergent pathogenic pathways of cartilage degradation in osteoarthritis and strategies in cartilage regenerative treatment. Chondrocytes, fibroblast-like synoviocytes (FLSs) and subchondral bone osteoblasts (SBOs) are shown. Mechanical stress and biochemical stimuli on chondrocytes result in increased production of proinflammatory mediators, extracellular matrix (ECM) degrading enzymes, and hypocellularity caused by apoptosis. Activation of NF-κB induces HIF-2α in chondrocytes, which leads to upregulated production of MMP-13 and MMP-3 to degrade ECM and induces expression of RUNX2, Ihh, Col10 and VEGF (not shown) to promote endochondral ossification. Increased expression of TGF-β is seen in SBO and FLS of OA and contributes to development of osteoarthritis. TGF-β signaling skewing from classical Smad2/3 to Smad1/5/8 leads to hypertrophic differentiation of chondrocytes. Inhibition of the inflammatory mediators or interruption of intracellular signaling pathways by mAbs, chemical compounds, and fusion proteins represents recent approaches to the strategies for anti-inflammatory and anti-degradative treatments. Cell-based or cell-homing therapies are a viable means for pro-chondrogenesis facilitating cartilage regeneration, including scaffolding systems containing stem cell homing factors (1, 2) or progenitor cell chemotaxis followed by chondrogenic stimulation (3), autologous or matrix-assisted autologous chondrocyte implantation (ACI or MACI) (4), in vivo generated cartilage from endogenous chondrogenic-differentiated stem cells (5), mesenchymal stem cell implantation (6), and growth factor-induced stem cell expansion and pro-chondrogenic differentiation with augmented ECM production (7). Integrated approach is a combined therapy that utilizes all means of most advanced technologies available targeted, genetic, and cellular therapies to treat and regenerate cartilage faster, safer and more accurately and effectively (8). Osteoarthritis and Cartilage 2017 25, 1577-1587DOI: (10.1016/j.joca.2017.07.004) Copyright © 2017 Osteoarthritis Research Society International Terms and Conditions

Fig. 2 Current and emerging principles of regenerative therapies for OA treatment. Current clinical approaches in regenerative treatment of OA concentrate mainly on the disease at moderate and advanced stages primarily using autologous mesenchymal stem cells (MSCs) and a variety of bioscaffolds, separately or in combination. Patients can alleviate their symptoms with various degrees of improved clinical outcomes. Specific homing of tissue-derived stem/progenitor cells to the site of cartilage defect using chemotactic agents or activation of resident cells with regenerative potential chemically or biologically is a nearly noninvasive approach, potentially more acceptable for patients having early sign of disease. MSC may be genetically modified or optimized for improvement in regenerative and reparative capabilities. Scaffolds and microfracture techniques are invasive treatments for later stages of OA. As the prevalence of OA is increasing and continues to rise markedly with age, earlier and less invasive therapeutic regimens may not only offer the possibility of halting disease progression more effectively but also increase the likelihood of cure for OA at earlier stages. Osteoarthritis and Cartilage 2017 25, 1577-1587DOI: (10.1016/j.joca.2017.07.004) Copyright © 2017 Osteoarthritis Research Society International Terms and Conditions